The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Delivery Systems Market Research Report 2025
Synopsis
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Gene Delivery Systems market was valued at US$ 7077.6 million in 2023 and is anticipated to reach US$ 9760.3 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.
Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
This report aims to provide a comprehensive presentation of the global market for Gene Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery Systems.
Report Scope
The Gene Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Amgen
Oxford BioMedica
SIBIONO
Shanghai Sunway Biotech
Roche
Pfizer
Bayer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
HSCI
Epeius Biotechnologies
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Combined Hybrid System
Segment by Application
Infectious Diseases
Oncology
Ophthalmology
Urology
Diabetes
CNS
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Gene Delivery Systems market was valued at US$ 7077.6 million in 2023 and is anticipated to reach US$ 9760.3 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.
Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
This report aims to provide a comprehensive presentation of the global market for Gene Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery Systems.
Report Scope
The Gene Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Amgen
Oxford BioMedica
SIBIONO
Shanghai Sunway Biotech
Roche
Pfizer
Bayer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
HSCI
Epeius Biotechnologies
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Combined Hybrid System
Segment by Application
Infectious Diseases
Oncology
Ophthalmology
Urology
Diabetes
CNS
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.2.4 Combined Hybrid System
1.3 Market by Application
1.3.1 Global Gene Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Ophthalmology
1.3.5 Urology
1.3.6 Diabetes
1.3.7 CNS
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery Systems Market Perspective (2019-2030)
2.2 Gene Delivery Systems Growth Trends by Region
2.2.1 Global Gene Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Gene Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Gene Delivery Systems Market Dynamics
2.3.1 Gene Delivery Systems Industry Trends
2.3.2 Gene Delivery Systems Market Drivers
2.3.3 Gene Delivery Systems Market Challenges
2.3.4 Gene Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Delivery Systems Players by Revenue
3.1.1 Global Top Gene Delivery Systems Players by Revenue (2019-2024)
3.1.2 Global Gene Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Gene Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Delivery Systems Revenue
3.4 Global Gene Delivery Systems Market Concentration Ratio
3.4.1 Global Gene Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery Systems Revenue in 2023
3.5 Gene Delivery Systems Key Players Head office and Area Served
3.6 Key Players Gene Delivery Systems Product Solution and Service
3.7 Date of Enter into Gene Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Delivery Systems Breakdown Data by Type
4.1 Global Gene Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Gene Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Gene Delivery Systems Breakdown Data by Application
5.1 Global Gene Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Gene Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Delivery Systems Market Size (2019-2030)
6.2 North America Gene Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Delivery Systems Market Size by Country (2019-2024)
6.4 North America Gene Delivery Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Delivery Systems Market Size (2019-2030)
7.2 Europe Gene Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Delivery Systems Market Size by Country (2019-2024)
7.4 Europe Gene Delivery Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Delivery Systems Market Size (2019-2030)
8.2 Asia-Pacific Gene Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Delivery Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Delivery Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Delivery Systems Market Size (2019-2030)
9.2 Latin America Gene Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Delivery Systems Market Size by Country (2019-2024)
9.4 Latin America Gene Delivery Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Delivery Systems Market Size (2019-2030)
10.2 Middle East & Africa Gene Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Delivery Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Delivery Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Gene Delivery Systems Introduction
11.1.4 Novartis Revenue in Gene Delivery Systems Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Gene Delivery Systems Introduction
11.2.4 Amgen Revenue in Gene Delivery Systems Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Gene Delivery Systems Introduction
11.3.4 Oxford BioMedica Revenue in Gene Delivery Systems Business (2019-2024)
11.3.5 Oxford BioMedica Recent Development
11.4 SIBIONO
11.4.1 SIBIONO Company Detail
11.4.2 SIBIONO Business Overview
11.4.3 SIBIONO Gene Delivery Systems Introduction
11.4.4 SIBIONO Revenue in Gene Delivery Systems Business (2019-2024)
11.4.5 SIBIONO Recent Development
11.5 Shanghai Sunway Biotech
11.5.1 Shanghai Sunway Biotech Company Detail
11.5.2 Shanghai Sunway Biotech Business Overview
11.5.3 Shanghai Sunway Biotech Gene Delivery Systems Introduction
11.5.4 Shanghai Sunway Biotech Revenue in Gene Delivery Systems Business (2019-2024)
11.5.5 Shanghai Sunway Biotech Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Gene Delivery Systems Introduction
11.6.4 Roche Revenue in Gene Delivery Systems Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Gene Delivery Systems Introduction
11.7.4 Pfizer Revenue in Gene Delivery Systems Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Gene Delivery Systems Introduction
11.8.4 Bayer Revenue in Gene Delivery Systems Business (2019-2024)
11.8.5 Bayer Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Gene Delivery Systems Introduction
11.9.4 Johnson & Johnson Revenue in Gene Delivery Systems Business (2019-2024)
11.9.5 Johnson & Johnson Recent Development
11.10 Becton Dickinson
11.10.1 Becton Dickinson Company Detail
11.10.2 Becton Dickinson Business Overview
11.10.3 Becton Dickinson Gene Delivery Systems Introduction
11.10.4 Becton Dickinson Revenue in Gene Delivery Systems Business (2019-2024)
11.10.5 Becton Dickinson Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Gene Delivery Systems Introduction
11.11.4 AstraZeneca Revenue in Gene Delivery Systems Business (2019-2024)
11.11.5 AstraZeneca Recent Development
11.12 Baxter
11.12.1 Baxter Company Detail
11.12.2 Baxter Business Overview
11.12.3 Baxter Gene Delivery Systems Introduction
11.12.4 Baxter Revenue in Gene Delivery Systems Business (2019-2024)
11.12.5 Baxter Recent Development
11.13 HSCI
11.13.1 HSCI Company Detail
11.13.2 HSCI Business Overview
11.13.3 HSCI Gene Delivery Systems Introduction
11.13.4 HSCI Revenue in Gene Delivery Systems Business (2019-2024)
11.13.5 HSCI Recent Development
11.14 Epeius Biotechnologies
11.14.1 Epeius Biotechnologies Company Detail
11.14.2 Epeius Biotechnologies Business Overview
11.14.3 Epeius Biotechnologies Gene Delivery Systems Introduction
11.14.4 Epeius Biotechnologies Revenue in Gene Delivery Systems Business (2019-2024)
11.14.5 Epeius Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
